General Information
BounceWatch is an independent company data service, not affiliated with MenoGeniX, Inc. To contact MenoGeniX, Inc, visit menogenix.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does MenoGeniX, Inc compare?
A PDF of MenoGeniX, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting MenoGeniX, Inc soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is MenoGeniX, Inc on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About MenoGeniX, Inc
Business keywords: clinical stage, biopharmaceutical, women's health, menopause, hot flashes, vasomotor symptoms, development, treatment, private company, innovation, bioscience, therapeutics
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | Undisclosed | 1 |
National Institutes of Health
|
03 May 2018 |
| Seed Round | $200.00K | - |
|
16 Sep 2016 |
| Seed Round | $405.00K | - |
|
14 Aug 2014 |
| Seed Round | $500.00K | - |
|
31 Jul 2012 |
MenoGeniX, Inc Alternatives & Competitors
View All AlternativesTARGETING DIFFICULT TO TREAT CANCERS
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
Pioneering advanced immunotherapies to amplify cancer treatment options and improve patient outcomes...
FAQ About MenoGeniX, Inc
Source: BounceWatch company record for MenoGeniX, Inc, https://bouncewatch.com/company/menogenix, updated 28 October 2024. When citing, please name BounceWatch and link this page.